title: Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study.
authors.affiliation: Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany; Autoinflammation Reference Center Charité, Charité - Universitätsmedizin, Berlin, Germany.
authors.forename: Karoline
authors.initials: K
authors.lastname: Krause
authors.affiliation: Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany.
authors.forename: Aos
authors.initials: A
authors.lastname: Mahamed
authors.affiliation: Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany.
authors.forename: Karsten
authors.initials: K
authors.lastname: Weller
authors.affiliation: Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Metz
authors.affiliation: Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany; Autoinflammation Reference Center Charité, Charité - Universitätsmedizin, Berlin, Germany.
authors.forename: Torsten
authors.initials: T
authors.lastname: Zuberbier
authors.affiliation: Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany; Autoinflammation Reference Center Charité, Charité - Universitätsmedizin, Berlin, Germany. Electronic address: marcus.maurer@charite.de.
authors.forename: Marcus
authors.initials: M
authors.lastname: Maurer
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000097:blood; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors*; D015850:Interleukin-6 / Q000097:blood; D010865:Pilot Projects; D016896:Treatment Outcome; D014581:Urticaria / Q000097:blood / Q000188:drug therapy*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000097:blood / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053590:Interleukin 1 Receptor Antagonist Protein; D053583:Interleukin-1beta; D015850:Interleukin-6; C541220:canakinumab; D002097:C-Reactive Protein